ARHS enters its May 14 Q1 2026 print on the back foot — the stock is down 14% in a week, analysts have cut targets across the board, and the fundamentals reveal a business running on razor-thin margins.
The analyst-side story is relentlessly one-directional. Five firms trimmed their price targets in the past four days alone, none upgrading their stance. TD Cowen (Buy, cut to $8) and Stifel (Buy, cut to $11) remain formally positive but have been walking targets lower for months. Piper Sandler made the sharpest revision on Monday, slashing its Neutral target to $8 from $11 — a 27% cut on the day before earnings. The Street's consensus target now averages $8.94 against a closing price of $6.12, implying roughly 42% upside on paper. But the consistent downward drift in targets signals that analysts are chasing the stock lower, not getting ahead of it.
The bull case rests on brand differentiation, a tariff-mitigation plan, and new merchandising momentum. Bears point to a profitability squeeze that is harder to dismiss. EBITDA margins clocked just 4.6% last quarter, with SG&A consuming nearly all the gross profit. Net income for the most recent quarter came in at $2.2 million on $314 million of revenue — a margin of under 1%. Inventory obsolescence charges and rising occupancy costs have eroded what was once a cleaner margin profile. The debate heading into Thursday is not whether Arhaus has a quality product, but whether the cost structure can flex quickly enough given ongoing demand volatility and the tariff environment.
Short positioning is genuinely present but not extreme. Short interest has climbed to 6.1% of the free float, up roughly 3.6% in a single session on May 8, though essentially flat over the week. Borrow conditions remain loose — cost to borrow is just 0.53%, and availability is well within normal ranges — suggesting short sellers are not scrambling for stock. The options market offers little drama either: the put/call ratio at 0.44 is virtually on its 20-day average, with a z-score near zero. There is no obvious panic hedge being built into the options book ahead of the release. Peers WSM and RH were both up on the week, while ARHS shed 13% — so the underperformance is specific to Arhaus rather than a broad category selloff.
One historical data point sharpens the stakes. The company's most recent earnings event, in early May, produced a one-day decline of 14.3%. The stock enters this print already 14% below where it was a week ago. Thursday's release will test whether the wave of analyst target cuts and the ongoing compression in EBITDA margins has already been priced into the stock — or whether there is more reset to come.
See the live data behind this article on ORTEX.
Open ARHS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
